I began investing in the stock market for the first time back in April of this year. At 32 years old, I had never given investing any serious thought prior to this year. My mind held onto the antiquated notion of, outside of my 401k, the stock market and investing was something only rich people did. So I have a lot of conceptual catching up to do! Definitely not something you master in three months 🙂 I am pretty satisfied with my overall P/L despite it being in t...
Arrayfunction
OPGreenhorn Dav
:
Thanks for the encouragement! One thing I forgot to mention is how much I have always appreciated the Moomoo community. I can't remember a single time I had a negative interaction with another user. Reflecting now, that played a huge role in making me feel like I belong here and kept any big loss or dumb play make me hit the eject button. Of all the places on the internet, who would have thought it'd be a group of stock traders where everyone gets along and respects one another? So a big thanks to anyone else out there reading this too!
$AC Immune (ACIU.US)$AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer’s Disease AC Immune SA - AC Immune to Receive Upfront Payment of $100 Mln Upon Closing
2
4
Report
Trytosaveabit
OP
:
AC Immune Eligible for $2.1B in Potential Milestones
$Takeda Pharmaceutical (TAK.US)$Takeda Says Primary And Key Secondary Endpoints Were Met In Narcolepsy Type 1 Phase 2b Trial; The NT1 trial TAK-861-2001 evaluating TAK-861 in 112 patients demonstrated statistically significant and clinically meaningful improvement in objective and subjective measures of wakefulness compared to placebo at week 8 including on the primary endpoint Maintenance of Wakefulness Test (MWT) (p < 0.001). Plans To Initiate Global Phase 3 Trials Of TAK-861 In Narcolep...
The emergence of artificial intelligence (AI) in healthcare is transforming the medical industry by improving research, diagnoses, and treatment outcomes, and even drug discovery. Let's take a look at a few of the different types of artificial intelligence and healthcare industry benefits that can be derived from their use. The Competition to Discover the First Drug with AI Insilico Medicine, ...
11
1
Report
No comment yet
Sign in to post a comment
Trending Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Takeda Pharmaceutical Stock Forum
Can This New Drug Cut Blood Draws by 72% for Polycythemia Vera Patients?
New TAKHZYRO Pen Makes HAE Treatment More Accessible - What This Means for Patients
AC Immune SA - AC Immune to Receive Upfront Payment of $100 Mln Upon Closing
The NT1 trial TAK-861-2001 evaluating TAK-861 in 112 patients demonstrated statistically significant and clinically meaningful improvement in objective and subjective measures of wakefulness compared to placebo at week 8 including on the primary endpoint Maintenance of Wakefulness Test (MWT) (p < 0.001).
Plans To Initiate Global Phase 3 Trials Of TAK-861 In Narcolep...
Let's take a look at a few of the different types of artificial intelligence and healthcare industry benefits that can be derived from their use.
The Competition to Discover the First Drug with AI
Insilico Medicine, ...
No comment yet